April 6, 2017
Theratechnologies released their financial results for the first quarter of 2017.
April 5, 2017
Prometic Life Sciences completed an FDA filing for their plasminogen biologics license application to treat patients with plasminogen congenital deficiency.
March 31, 2017
Prometic Life Sciences (TSX:PLI, OTCQX:PFSCF) released their financial result for 2016 and its fourth quarter.